Abiopharma

🔍 Kurdikar Devdatt (Executive)

Company: ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 154 shares of Phantom Stock Units at $89.08 per share (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,928.85 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4

Footnotes:

• F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4: Includes 4.508 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.